Status:
COMPLETED
Anti-inflammatory Markers in Endometrioma
Lead Sponsor:
Muğla Sıtkı Koçman University
Conditions:
Endometrioma
Inflammation
Eligibility:
FEMALE
18+ years
Brief Summary
Investigators aimed to measure the serum levels of adropin, salusin-α, netrin-1, and nesfatin-1, anti-inflammatory effects of which have been demonstrated previously, in endometriosis patients and to ...
Detailed Description
Endometriosis is defined as the presence of endometrial gland and stroma outside the endometrial cavity affecting almost 10% of the women of reproductive age. Although benign, it disrupts the quality ...
Eligibility Criteria
Inclusion
- ·Histopathologically confirmed diagnosis of endometrioma
Exclusion
- Any patients with DM,
- chronic kidney disease (CKD),
- CAD,
- heart failure (HF),
- cerebrovascular accident (CVA),
- malignancy,
- rheumatoid disorder,
- liver disease, and
- active infections were excluded from the study.
Key Trial Info
Start Date :
August 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2020
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04371133
Start Date
August 15 2018
End Date
March 15 2020
Last Update
May 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mugla Sıtkı Kocman University Faculty of Medicine
Muğla, Turkey (Türkiye), 48000